David C. Hastings - 18 Jan 2022 Form 4 Insider Report for Entasis Therapeutics Holdings Inc. (ETTX)

Role
Director
Signature
Elizabeth M. Keiley as Attorney-in-Fact for David Hastings
Issuer symbol
ETTX
Transactions as of
18 Jan 2022
Transactions value $
$0
Form type
4
Filing time
19 Jan 2022, 15:01:18
Previous filing
15 Feb 2022
Next filing
20 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETTX Common Stock Award $0 +27.5K +125% $0.00 49.5K 18 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This award vests in full on the first anniversary of the date of grant, subject to the reporting person's continued service as a director of the Company.